M12.259 Villonodular synovitis (pigmented), unspecified hip

Name of the Condition

• Villonodular synovitis (pigmented), unspecified hip (ICD-10 Code: M12.259)

Summary

Villonodular synovitis (pigmented), unspecified hip is a rare, benign proliferative disorder of the synovium (joint lining) characterized by abnormal growth of tissue and hemosiderin deposition. It typically presents as localized joint swelling and pain, often affecting the hip joint. The condition is non-malignant but may cause functional impairment due to mechanical obstruction or joint damage.

Causes

The exact cause is unknown, but it is thought to arise from a reactive or inflammatory process within the synovium. Trauma, chronic irritation, or abnormal blood vessel formation may contribute to the development of the proliferative tissue. The pigmented appearance is due to hemosiderin, a byproduct of old blood, deposited in the synovial tissue.

Risk Factors

• Previous joint injury or surgery.
• Chronic joint inflammation or irritation.
• Age: More common in young to middle-aged adults.
• Gender: Slightly more prevalent in males.

Symptoms

• Persistent joint swelling, often painless or mildly painful.
• Limited range of motion or stiffness in the affected hip.
• Palpable mass or nodule within the joint.
• Recurrent effusions (fluid buildup) in the joint.

Diagnosis

Physical examination to assess joint swelling, tenderness, or range of motion. Imaging tests such as MRI or ultrasound may be used to evaluate soft tissue changes. Arthroscopy with biopsy is often required for definitive diagnosis, as the condition can mimic other joint disorders.

Treatment Options

• Surgical removal of the abnormal synovial tissue (synovectomy) to relieve symptoms and prevent recurrence.
• Non-surgical management with activity modification, physical therapy, or anti-inflammatory medications for mild cases.
• Radiation therapy in rare instances to reduce recurrence risk after surgery.

Prognosis and Follow-Up

Prognosis is generally good with appropriate treatment, though recurrence is possible. Regular follow-up with imaging or clinical assessment may be recommended to monitor for recurrence, especially if the condition was not fully excised.

Complications

• Recurrence of the condition after treatment.
• Joint stiffness or limited mobility if extensive tissue removal is required.
• Rare progression to degenerative joint disease over time.

Lifestyle & Prevention

• Avoid activities that exacerbate joint pain or swelling.
• Maintain a healthy weight to reduce hip joint stress.
• Promptly address any joint injuries or inflammation to minimize long-term irritation.

When to Seek Professional Help

Seek medical attention if you experience persistent hip swelling, pain, or reduced mobility that interferes with daily activities. Early evaluation is important to prevent complications and guide appropriate management.

Tips for Medical Coders

Document the affected hip (unspecified) and confirm the pigmented nature of the synovitis. Ensure clinical correlation with imaging or biopsy results to support the diagnosis. Note any surgical interventions or follow-up care for accurate coding and reporting.